相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations
Stamatis Karakonstantis et al.
INFECTION (2022)
Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms
Xiufeng Zhang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Acinetobacter baumannii Can Survive with an Outer Membrane Lacking Lipooligosaccharide Due to Structural Support from Elongasome Peptidoglycan Synthesis
Brent W. Simpson et al.
MBIO (2021)
Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii
Hector Olmeda-Lopez et al.
ANTIBIOTICS-BASEL (2021)
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
Stamatis Karakonstantis et al.
ANTIBIOTICS-BASEL (2021)
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria
Firdoos Ahmad Gogry et al.
FRONTIERS IN MEDICINE (2021)
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
Jacinda C. Abdul-Mutakabbir et al.
ANTIBIOTICS-BASEL (2021)
Characterization of multidrug-resistant Acinetobacter baumannii strain ATCC BAA1605 using whole-genome sequencing
Kah Ern Ten et al.
BMC RESEARCH NOTES (2021)
Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options
Stamatis Karakonstantis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains
Ahmet Sertcelik et al.
MICROBIAL DRUG RESISTANCE (2020)
Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii
Stefanie Gerson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
Ali Pormohammad et al.
MICROBIAL PATHOGENESIS (2020)
Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme
Go Kamoshida et al.
FRONTIERS IN MICROBIOLOGY (2020)
A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline inAcinetobacter baumannii
Stamatis Karakonstantis
JOURNAL OF CHEMOTHERAPY (2020)
Treatment options forK. pneumoniae,P. aeruginosaandA. baumanniico-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
Stamatis Karakonstantis et al.
INFECTION (2020)
Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients
S. Karakonstantis et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
Mohamed Abd El-Gawad El-Sayed Ahmed et al.
EMERGING MICROBES & INFECTIONS (2020)
Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
Carole Ayoub Moubareck et al.
ANTIBIOTICS-BASEL (2020)
Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii
J. -Y. Lee et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
Vincent Trebosc et al.
MBIO (2019)
Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo
Stefanie Gerson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
Mohammad Hamidian et al.
MICROBIAL GENOMICS (2019)
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
Yaakov Dickstein et al.
CLINICAL INFECTIOUS DISEASES (2019)
Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin
Matthew Joseph Powers et al.
MOLECULAR MICROBIOLOGY (2018)
Uncovering the mechanisms of Acinetobacter baumannii virulence
Christian M. Harding et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat
William Gustavo Lima et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii
Ali Mohammadi Bardbari et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Bacterial EndoMS/NucS acts as a clamp-mediated mismatch endonuclease to prevent asymmetric accumulation of replication errors
Norihiko Takemoto et al.
NUCLEIC ACIDS RESEARCH (2018)
Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
Marta Carretero-Ledesma et al.
VIRULENCE (2018)
Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii
Zahra Farshadzadeh et al.
FRONTIERS IN MICROBIOLOGY (2018)
Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii
Mustapha M. Mustapha et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Resistance to polymyxins in Gram-negative organisms
Katy Jeannot et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
Ji-Young Lee et al.
SCIENTIFIC REPORTS (2017)
Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads
Ryan R. Wick et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A-baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques
Micheline A. H. Soudeiha et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Chang-Ro Lee et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Epidemiology and Genetic Diversity of Colistin Nonsusceptible Nosocomial Acinetobacter baumannii Strains from Russia for 2013-2014
Eugene A. Sheck et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2017)
Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii
Kwan Soo Ko et al.
PRECISION AND FUTURE MEDICINE (2017)
The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
Xinli Mu et al.
FRONTIERS IN MICROBIOLOGY (2016)
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data
O. Oikonomou et al.
BMC INFECTIOUS DISEASES (2015)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Colistin, mechanisms and prevalence of resistance
Abed Zahedi Bialvaei et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro
Xavier Vila-Farres et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide
Meritxell Garcia-Quintanilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Abiola O. Olaitan et al.
FRONTIERS IN MICROBIOLOGY (2014)
Acinetobacter baumannii: evolution of a global pathogen
Luisa C. S. Antunes et al.
PATHOGENS AND DISEASE (2014)
Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
Emil Lesho et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fast Assessment of Resistance to Carbapenems and Ciprofloxacin of Clinical Strains of Acinetobacter baumannii
German Bou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
Luis A. Arroyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
Alejandro Beceiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
Sidharth Chopra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea
Young Kyoung Park et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Glenn A. Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The epidemiology and control of Acinetobacter baumannii in health care facilities
PE Fournier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate
DX Peng et al.
INFECTION AND IMMUNITY (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)